Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis.

Abstract

A patient with rheumatoid arthritis developed a reversible, primary cutaneous, large B cell lymphoma during prolonged methotrexate (MTX) treatment. Regression of the skin lesions after discontinuation of the drug suggested a close relationship to MTX. Increased clinical awareness, discontinuation of MTX, and close observation are important in the initial… (More)

Topics

Cite this paper

@article{Fam2000PrimaryCB, title={Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis.}, author={A. G. Fam and Bayrdo Perez-Ordo{\~n}ez and Kevin Robert Imrie}, journal={The Journal of rheumatology}, year={2000}, volume={27 6}, pages={1546-9} }